Mirati Therapeutics, Inc.
MRTXDelisted Jan 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001576263
Mirati Therapeutics, Inc. was delisted on Jan 23, 2024; its insiders filed their last Form 4 on Jan 25, 2024; 218 institutions reported holding it in 13F filings for Q4 2023, worth $4.66B in total; no superinvestor held it.
Holders of 5% or more of MRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mirati Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Mirati Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
31 Schedule 13D and 13G filings on Mirati Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2024 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Baker Bros. Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 8, 2024 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20242:08 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jan 25, 2024 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Dec 27, 2023 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Oct 12, 2023 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Oct 2, 2023 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Aug 16, 2023 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | RTW Investments, LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Jan 10, 202212:54 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20215:23 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Mirati Therapeutics, Inc. shares.
No Form 144 notices for Mirati Therapeutics, Inc. are on file.